Investigating the Factors Associated with the Level of Expression of Estrogen and Progesterone Receptors in Patients Suffering from Colorectal Cancer

Table 2

Distribution of clinical and pathological covariates in according to ER and PR expression.

Characteristic	ER expression			value	PR expression			value
	Low (%)	Moderate (%)	High (%)		Low (%)	Moderate (%)	High (%)
Gender
Male	22 (68.8)	8 (25)	2 (6.3)	0.499	23 (67.6)	7 (20.6)	4 (11.8)	0.774
Female	9 (52.9)	7 (41.2)	1 (5.9)		10 (58.8)	5 (29.4)	2 (11.8)
Age (years)
<50	4 (28.6)	7 (50)	3 (21.4)	0.001	4 (26.7)	5 (33.3)	6 (40)	0.001
≥50	27 (77.1)	8 (22.9)	0 (0)		29 (80.6)	7 (19.4)	0 (0)
Using cigarette
Yes	11 (68.8)	5 (31.2)	0 (0)	0.456	12 (66.7)	5 (27.8)	1 (5.6)	0.565
No	20 (60.6)	10 (30.3)	3 (9.1)		21 (63.6)	7 (21.2)	5 (15.2)
Using opium
Yes	25 (86.2)	4 (13.8)	0 (0)	0.001	27 (87.1)	3 (9.7)	1 (3.2)	0.001
No	6 (30)	11 (55)	3 (15)		6 (30)	9 (45)	5 (25)
Using hookah
Yes	8 (72.7)	2 (18.2)	1 (9.1)	0.571	8 (66.6)	2 (16.7)	2 (16.7)	0.725
No	23 (60.5)	13 (34.2)	2 (5.3)		25 (64.1)	10 (25.6)	4 (10.3)
History of inflammatory bowel diseases
Yes	4 (44.4)	4 (44.4)	1 (11.2)	0.364	4 (44.5)	2 (22.2)	3 (33.3)	0.091
No	27 (67.5)	11 (27.5)	2 (5)		29 (69)	10 (23.8)	3 (7.1)
Familial history of colorectal cancer
Yes	1 (14.3)	4 (57.1)	2 (28.6)	0.004	1 (14.3)	3 (42.9)	3 (42.9)	0.004
No	30 (71.4)	11 (26.2)	1 (2.4)		32 (72.7)	9 (20.5)	3 (6.8)
Grade
I	0 (0)	7 (77.8)	2 (22.2)	0.001	0 (0)	5 (50)	5 (50)	0.001
II	8 (53.3)	6 (40)	5 (50)		9 (56.2)	6 (37.5)	1 (4)
III	23 (92)	2 (8)	0 (0)		24 (96)	1 (6.3)	0 (0)